Levetiracetam News

← Back to News Overview


Levetiracetam currently has 0 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Levetiracetam with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
  • Original indication: Keppra is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy. Keppra is...
  • Evidence level: L2
  • Predicted indications (20):
    • visual epilepsy (100.0%)
    • audiogenic seizures (100.0%)
    • eating seizures (100.0%)
    • startle epilepsy (100.0%)
    • micturation-induced seizures (100.0%)
    • orgasm-induced seizures (100.0%)
    • thinking seizures (100.0%)
    • reading seizures (99.9%)
    • status epilepticus (99.9%)
    • beta-ketothiolase deficiency (99.9%)
    • partial epilepsy (99.9%)
    • 14q12 microdeletion syndrome (99.9%)
    • Rett syndrome, congenital variant (99.9%)
    • restless legs syndrome (99.9%)
    • adolescent/adult onset autosomal dominant epilepsy with auditory features (99.8%)
    • epilepsy with generalized tonic-clonic seizures (99.8%)
    • guanidinoacetate methyltransferase deficiency (99.8%)
    • partial motor epilepsy (99.6%)
    • trigeminal nerve neoplasm (99.5%)
    • epilepsy (99.2%)

View full drug report →

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.

Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.